CYP17A1
Summary: This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. It has both 17alpha-hydroxylase and 17,20-lyase activities and is a key enzyme in the steroidogenic pathway that produces progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens. Mutations in this gene are associated with isolated steroid-17 alpha-hydroxylase deficiency, 17-alpha-hydroxylase/17,20-lyase deficiency, pseudohermaphroditism, and adrenal hyperplasia. [provided by RefSeq, Jul 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
cytochrome P450 family 17 subfamily A member 1 | MIM:609300 | Ensembl:ENSG00000148795 | HGNC:HGNC:2593 | PA27090 | 10q24.32 |
GO terms in CYP17A1
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | NAS | GO:0005783 | endoplasmic reticulum |
CC | TAS | GO:0005789 | endoplasmic reticulum membrane |
CC | IEA | GO:0030424 | axon |
CC | IEA | GO:0043025 | neuronal cell body |
BP | TAS | GO:0006694 | steroid biosynthetic process |
BP | TAS | GO:0006702 | androgen biosynthetic process |
BP | TAS | GO:0006704 | glucocorticoid biosynthetic process |
BP | TAS | GO:0007548 | sex differentiation |
BP | IDA | GO:0008202 | steroid metabolic process |
BP | TAS | GO:0016125 | sterol metabolic process |
BP | IBA | GO:0042446 | hormone biosynthetic process |
BP | IDA | GO:0042446 | hormone biosynthetic process |
BP | IBA | GO:0042448 | progesterone metabolic process |
BP | IDA | GO:0042448 | progesterone metabolic process |
BP | IEA | GO:0055114 | oxidation-reduction process |
MF | IBA | GO:0004508 | steroid 17-alpha-monooxygenase activity |
MF | IDA | GO:0004508 | steroid 17-alpha-monooxygenase activity |
MF | IMP | GO:0004508 | steroid 17-alpha-monooxygenase activity |
MF | TAS | GO:0004508 | steroid 17-alpha-monooxygenase activity |
MF | IEA | GO:0005506 | iron ion binding |
MF | TAS | GO:0019825 | oxygen binding |
MF | IDA | GO:0020037 | heme binding |
MF | IBA | GO:0047442 | 17-alpha-hydroxyprogesterone aldolase activity |
MF | IMP | GO:0047442 | 17-alpha-hydroxyprogesterone aldolase activity |
Gene expression in normal tissue: CYP17A1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CYP17A1
Database | Pathway ID | Pathway Des. |
---|---|---|
smpdb | SMP00068 | Androgen and Estrogen Metabolism |
smpdb | SMP00130 | Steroidogenesis |
smpdb | SMP00356 | 17-Beta Hydroxysteroid Dehydrogenase III Deficiency |
smpdb | SMP00371 | Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
smpdb | SMP00372 | Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency |
smpdb | SMP00373 | Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency |
smpdb | SMP00565 | Aromatase deficiency |
smpdb | SMP00566 | 17-alpha-hydroxylase deficiency (CYP17) |
smpdb | SMP00575 | 11-beta-hydroxylase deficiency (CYP11B1) |
smpdb | SMP00576 | 21-hydroxylase deficiency (CYP21) |
smpdb | SMP00577 | Corticosterone methyl oxidase I deficiency (CMO I) |
smpdb | SMP00578 | Corticosterone methyl oxidase II deficiency - CMO II |
smpdb | SMP00717 | Apparent mineralocorticoid excess syndrome |
smpdb | SMP00718 | 3-Beta-Hydroxysteroid Dehydrogenase Deficiency |
wikipathways | WP2263 | Androgen Receptor Network in Prostate Cancer |
wikipathways | WP237 | Glucocorticoid and Mineralcorticoid Metabolism |
wikipathways | WP43 | Oxidation by Cytochrome P450 |
wikipathways | WP496 | Steroid Biosynthesis |
wikipathways | WP702 | Metapathway biotransformation Phase I and II |
kegg | hsa00140 | Steroid hormone biosynthesis - Homo sapiens (human) |
kegg | hsa04913 | Ovarian steroidogenesis - Homo sapiens (human) |
kegg | hsa04917 | Prolactin signaling pathway - Homo sapiens (human) |
kegg | hsa04927 | Cortisol synthesis and secretion - Homo sapiens (human) |
kegg | hsa04934 | Cushing,s syndrome - Homo sapiens (human) |
humancyc | PWY-7305 | superpathway of steroid hormone biosynthesis |
humancyc | PWY66-378 | androgen biosynthesis |
humancyc | PWY66-381 | glucocorticoid biosynthesis |
reactome | R-HSA-1430728 | Metabolism |
reactome | R-HSA-1643685 | Disease |
reactome | R-HSA-193048 | Androgen biosynthesis |
reactome | R-HSA-194002 | Glucocorticoid biosynthesis |
reactome | R-HSA-196071 | Metabolism of steroid hormones |
reactome | R-HSA-211859 | Biological oxidations |
reactome | R-HSA-211897 | Cytochrome P450 - arranged by substrate type |
reactome | R-HSA-211945 | Phase I - Functionalization of compounds |
reactome | R-HSA-211976 | Endogenous sterols |
reactome | R-HSA-556833 | Metabolism of lipids |
reactome | R-HSA-5579028 | Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5) |
reactome | R-HSA-5579029 | Metabolic disorders of biological oxidation enzymes |
reactome | R-HSA-5668914 | Diseases of metabolism |
reactome | R-HSA-8957322 | Metabolism of steroids |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD886 | Compound 1541A | 3 |
iGMDRD263 | AACOCF3 | 3 |
iGMDRD414 | MST-312 | 8 |
iGMDRD286 | Nsc 632839 | 6 |
iGMDRD289 | Parthenolide | 2 |
iGMDRD105 | Triptolide | 2 |
iGMDRD434 | BMS-536924 | 2 |
iGMDRD114 | Abiraterone | 1 |
iGMDRD103 | SN-38 | 3 |
iGMDRD251 | ML162 | 3 |
iGMDRD121 | GMX1778 | 2 |
iGMDRD177 | Teniposide | 3 |
iGMDRD945 | ML214 | 4 |
iGMDRD341 | Triacsin c | 1 |
iGMDRD219 | Bax channel blocker | 2 |
iGMDRD116 | CD437 | 3 |
iGMDRD268 | Cerulenin | 1 |
iGMDRD23 | Gossypol | 5 |
iGMDRD188 | Piperlongumine | 4 |
iGMDRD887 | Compound 23 citrate | 2 |
iGMDRD577 | BIX01294 | 2 |
iGMDRD562 | Navitoclax | 7 |
iGMDRD780 | PP-30 | 2 |
iGMDRD782 | DC-45-A2 | 6 |
iGMDRD318 | PAC-1 | 3 |
iGMDRD870 | BRD63610 | 1 |
iGMDRD138 | PX 12 | 1 |
iGMDRD474 | Avrainvillamide | 3 |
iGMDRD255 | SB225002 | 3 |
iGMDRD487 | Enzalutamide | 1 |
iGMDRD297 | Austocystin D | 4 |
iGMDRD466 | Chaetocin | 1 |
iGMDRD634 | SCHEMBL2608041 | 2 |
iGMDRD446 | LY 2183240 | 2 |
iGMDRD61 | Kinetin riboside | 4 |
iGMDRD152 | 179324-69-7 | 5 |
iGMDRD144 | NSC95397 | 4 |
iGMDRD427 | ABT737 | 1 |
iGMDRD126 | Tipifarnib | 2 |
iGMDRD420 | Leucascandrolide A | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CYP17A1